Chen Lu, Wang Yanping, Li Shulin, Zuo Bangjie, Zhang Xiangyu, Wang Fengzhen, Sun Dong
Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Department of Internal Medicine and Diagnostics, Xuzhou Medical University, Xuzhou, China.
Theranostics. 2020 Jul 25;10(20):9425-9442. doi: 10.7150/thno.43315. eCollection 2020.
Mesenchymal stem cells (MSCs) have emerged as ideal cell-based therapeutic candidates for the structural and functional restoration of the diseased kidney. Glial cell line-derived neurotrophic factor (GDNF) has been demonstrated to promote the therapeutic effect of MSCs on ameliorating renal injury. The mechanism may involve the transfer of endogenous molecules via paracrine factors to salvage injured cells, but these factors remain unknown. GDNF was transfected into human adipose mesenchymal stem cells a lentiviral transfection system, and exosomes were isolated (GDNF-AMSC-exos). Using the unilateral ureteral obstruction (UUO) mouse model and human umbilical vein endothelial cells (HUVECs) against hypoxia/serum deprivation (H/SD) injury models, we investigated whether GDNF-AMSC-exos ameliorate peritubular capillary (PTC) loss in tubulointerstitial fibrosis and whether this effect is mediated by the Sirtuin 1 (SIRT1) signaling pathway. Additionally, by using SIRT1 activators or siRNAs, the roles of the candidate mRNA and its downstream gene in GDNF-AMSC-exo-induced regulation of endothelial cell function were assessed. PTC characteristics were detected by fluorescent microangiography (FMA) and analyzed by the MATLAB software. The green fluorescent PKH67-labeled exosomes were visualized in the UUO kidneys and colocalized with CD81. GDNF-AMSC-exos significantly decreased PTC rarefaction and renal fibrosis scores in mice with UUO. studies revealed that GDNF-AMSC-exos exerted cytoprotective effects on HUVECs against H/SD injury by stimulating migration and angiogenesis as well as conferring apoptosis resistance. Mechanistically, GDNF-AMSC-exos enhanced SIRT1 signaling, which was accompanied by increased levels of phosphorylated endothelial nitric oxide synthase (p-eNOS). We also confirmed the SIRT1-eNOS interaction in HUVECs by immunoprecipitation. Furthermore, we observed a correlation of the PTC number with the SIRT1 expression level in the kidney . Our study unveiled a mechanism by which exosomes ameliorate renal fibrosis: GDNF-AMSC-exos may activate an angiogenesis program in surviving PTCs after injury by activating the SIRT1/eNOS signaling pathway.
间充质干细胞(MSCs)已成为用于患病肾脏结构和功能恢复的理想细胞治疗候选物。胶质细胞系源性神经营养因子(GDNF)已被证明可促进MSCs对改善肾损伤的治疗效果。其机制可能涉及通过旁分泌因子转移内源性分子以挽救受损细胞,但这些因子仍不清楚。使用慢病毒转染系统将GDNF转染到人脂肪间充质干细胞中,并分离出外泌体(GDNF-AMSC-exos)。利用单侧输尿管梗阻(UUO)小鼠模型和人脐静脉内皮细胞(HUVECs)对抗缺氧/血清剥夺(H/SD)损伤模型,我们研究了GDNF-AMSC-exos是否能改善肾小管间质纤维化中周细胞毛细血管(PTC)的丢失,以及这种作用是否由沉默调节蛋白1(SIRT1)信号通路介导。此外,通过使用SIRT1激活剂或小干扰RNA(siRNAs),评估了候选信使核糖核酸(mRNA)及其下游基因在GDNF-AMSC-exo诱导的内皮细胞功能调节中的作用。通过荧光微血管造影(FMA)检测PTC特征,并使用MATLAB软件进行分析。绿色荧光PKH67标记的外泌体在UUO肾脏中可见,并与CD81共定位。GDNF-AMSC-exos显著降低了UUO小鼠的PTC稀疏和肾纤维化评分。研究表明,GDNF-AMSC-exos通过刺激迁移和血管生成以及赋予抗凋亡能力,对HUVECs对抗H/SD损伤发挥细胞保护作用。从机制上讲,GDNF-AMSC-exos增强了SIRT1信号通路,这伴随着磷酸化内皮型一氧化氮合酶(p-eNOS)水平的升高。我们还通过免疫沉淀证实了HUVECs中SIRT1-eNOS的相互作用。此外,我们观察到肾脏中PTC数量与SIRT1表达水平之间存在相关性。我们的研究揭示了外泌体改善肾纤维化的机制:GDNF-AMSC-exos可能通过激活SIRT1/eNOS信号通路,在损伤后存活的PTC中激活血管生成程序。